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INTRODUCTION
Suicidal behavior represents a serious public health problem, as it is one of the major reasons of death among youth (1) . According to the World Health Organization, more than one million people die each year due to suicide and it represents 2% of deaths worldwide (2) . The association between suicidal behavior and genetic factors is thought to be approximately 30-50% (1, 3, 4) .
The endocannabinoid (EC) system is believed to have a pivotal role in the regulation of mood, cognition, motivation, and emotional homeostasis, which are impaired in patients with suicidal behavior (5) . The main role of the EC system seems to be the blockade of excessive excitatory or inhibitory activity in brain regions relevant to the regulation of pain, emotion, motivation, and cognition (6) . If EC system is dysfunctional, extremes of cortical excitation or inhibition may occur leading to neuropsychological states such as mania, hyperarousal, depression, anhedonia, or apathy. The behavioral effects of ECs are believed to be mediated through the main central cannabinoid receptor in the brain: the CB1 receptor. CB1 receptors are coded by the cannabinoid-1 receptor gene localized at 6q14-q15 in chromosomes. Many single nucleotide polymorphisms (SNPs) have been identified at the CNR1 locus so far (7) (8) (9) . Studies have reported EC system abnormalities in depression, schizophrenia, and suicide. Abnormalities in the CNR1 gene that codes for cannabinoid-1 receptors have been reported in psychiatric disorders (10) . Clinical data suggest that the hyperactivity of the EC system plays a role in the pathogenesis of suicide. Moreover, enhanced EC activity might be associated with impulsive behavior, a characteristic of suicide (11) .
One of the most demanding topics in psychiatry is how to protect patients from suicide attempts. Interestingly, some genes investigated in depression have not yet been studied in suicide. Identification of high-risk individuals through genomic screening of the CB1 receptor gene and environmental risk factors may offer a promising method for predicting patients who will likely attempt suicide or parasuicide. Our aim is to study whether there is an association between polymorphism of the CNR1 receptor with suicide attempts. We compared the findings from non-suicidal subjects with those from suicide-attempt victims to substantiate these findings.
METHODS

Participants and Study Protocol
The study included 115 suicide attempt (parasuicide) patients (mean age 25.57±8.52 years; range 16-67 years; 41 males, 74 females) recruited consecutively from the patients who were treated and followed up in the Emergency Department of Firat University Hospital, Elazig, Turkey between February 2010 and December 2010. A group of 69 unrelated healthy subjects (HC) (mean age 27.49±10.55 years; ranging from 16 to 58 years; 38 males, 31 females) was recruited consecutively. All patients and healthy subjects were of Turkish origin from the Upper Euphrates region in Turkey. The Institutional Ethics Committee approved the study and all of the participants gave informed consent before participation in the study.
Patients admitted to our emergency service with a "suicidal gesture" and those who took lower doses of medications as a salient behavior to draw attention were included. The exclusion criteria were accidental selfpoisonings or injuries, patients with known genetic diseases, patients who did not agree to participate in the study, and patients who were under 16 years of age. The recorded events included medically treated cases of parasuicide only; deliberate self-harm that was not brought to the attention of medical staff was not included. Patients, who were under 18 years of ageor who could not give informed consent due to health issues, were included if their parents provided informed consent. For each patient, a psychiatry consultation was ordered. The following data were collected for each patient by the emergency physician responsible for the patient: age and gender, the reason of suicide attempt, whether the attempt was impulsive or not, the method of attempted suicide, prior psychiatric treatment/ illness, previous suicide attempt/deliberate selfharm, any family history of suicide/ psychiatric illness and post-consultation diagnosis.
The control group included patients with minor trauma or medical staff who had no history of genetic diseases or suicide attempts. Each patient in the control group was evaluated by a psychiatrist. The healthy subjects were excluded if he/she or his/her relatives had a history of a suicide attempt or psychiatric illness.
A suicide attempt was defined as an act with a non-fatal outcome in which an individual deliberately caused self-harm or ingested a substance with the intent of self-harm (12) . The suicide attempts were classified as violent or non-violent according to the methods used and the severity of the attempt (13) . The violent attempts included hanging, stabbing, shooting, jumping from a building, walking in front of a moving vehicle, severe deliberate car accident, gas suffocation, drowning, electricity, or burning. The non-violent attempts included illicit or prescription drug overdose or rather superficial cuts on the wrists. Patients who used both violent and non-violent attempts were included in the violent group. Self poisoning was defined as the intentional self-administration of more than the prescribed dose of any drug, whether or not there was evidence that the act was intended to cause self-harm, and included poisoning with non-ingestible substances or gas, overdoses of recreational drugs, and severe alcohol intoxication where clinical staff considered such cases to be acts of self-harm (14) .
Peripheral blood samples were drawn from all of the participants into tubes containing ethylenediamine tetraacetate. The DNA was immediately extracted from the blood samples and then stored at -80 °C until the analysis of the cannabinoid gene SNP.
Genotype Analysis
Genomic DNA was extracted from peripheral blood leucocytes with the Promega DNA Isolation Kit (Madison, WI, USA) according to the manufacturer's instructions and kept at -20°C until testing. Polymerase chain reaction (PCR) amplifications of the related regions were carried out in 25 µl volumes of reaction mixtures containing 75 mM Tris-HCl (pH 8.8), 200 mM (NH4)2SO4, 0.1% Tween-20, 1.5 mM MgCl2, 200 mM of each dNTP, and 20 pmol of each set of specific primers. The thermocycler program (Eppendorf Mastercycle, Hamburg, Germany) consisted of an initial step of 94 ºC for 3 min, followed by 37 cycles of 95 ºC for 30 sec, 56 ºC for 30 sec, and 72 ºC for 30 sec, and a final extension at 72 ºC for 3 min. After PCR, fragments were digested with specific restriction enzymes (Fermentas, USA): MspI (New England Biolabs). The PCR products were analyzed through electrophoresis on a 2% agarose gel and identified with ethidium bromide (Sigma Aldrich, St. Louis, MO) staining under ultraviolet light (15) .
Statistical Analysis
The Statistical Package for the Social Sciences (SPSS 11.0, Chicago, IL, USA) was used for analysis. The genotype distributions of both the parasuicide and control groups were in agreement with expected values according to the Hardy-Weinberg equilibrium (p > 0.05). Quantitative data with normal distribution were presented as mean±standard deviation. Fisher's exact tests and Pearson's χ 2 tests were used to compare categorical variables and odds ratio and 95% confidence interval were used for the assessment of risk factors. P values less than 0.05 were considered as significant.
RESULTS
The mean ages of the parasuicide and control groups were 25.6±8.5 and 27.5±10.6 (P=0.017). The female ratios of the parasuicide and control groups were 64.3% (n=74) and 44.9% (n=31, respectively (P=0.014). The genotype distributions were significantly different between the parasuicide and control groups and this difference was attributed to the AG genotype rates (21.7% vs 44.9%, p=0.001, Table 1 ). None of the subjects in the control Of the patients with the AA genotype (n=6), 3 had been diagnosed with depression before their suicide attempts. Nonetheless, the majority of the patients with AG (68%, n=17) and GG (83.3%, n=70) genotypes did not have any psychiatric diagnosis prior to their suicide attempts. For all the genotypes, 78.3% (n=90) of the patients had not been previously diagnosed with psychiatric issues, and 14.8% (n=17) of the patients were previously diagnosed as having depression.
In the parasuicide group, CNR1 polymorphism differed significantly between those with a previous psychiatric diagnosis compared to suicide attempts without a previous diagnosis (p=0.004). Further evaluation with the Fischer exact test showed that the reason was the patients with the AG genotype. The frequencies of the AG genotype were 32% (n=8) and 68% (n=17) in the parasuicide patients with and without a psychiatric diagnosis, respectively (Table 3) . When logistic regression analysis was performed including two parameters (1) phenotype: AG and others, 2) people with and without previous psychiatric diagnoses) using the enter method, it was seen that previous psychiatric diagnoses were not significant. On the other hand, having the AG phenotype lowered the rate of admission to the ED due to parasuicide by 3.3 times (95% CI: 1.6-6.8).
After psychiatric consultation in the emergency department, all parasuicide patients with the AA genotype were diagnosed with psychiatric disorders (5 patients with depression and 1 patient with anxiety). The most frequently diagnosed psychiatric disorder among parasuicide patients in the ED was depression ( 
DISCUSSION
We aimed to identify whether there was a relationship between CNR1 gene polymorphism and suicide attempts by comparing parasuicide patients with healthy control subjects. We found a relationship between suicide attempts and the CNR1 gene polymorphism, but there was no association with the alleles. All six patients with homozygous mutant AA gene polymorphisms were in the parasuicide group and five of them were diagnosed as having depression. Nonetheless, heterozygous mutant AG gene polymorphism was shown to be lower in patients with suicide attempts.
Suicide is an unfavorable outcome of some psychiatric disorders. Post mortem studies have shown elevated levels of ECs in the dorsal prefrontal cortex of depressed suicide victims and alcoholic suicides compared with controls (10, 16) . All these conditions were associated with polymorphisms of the CNR1 gene that codes for CB1 receptors (16) . There are several alleles of the CNR1 gene involving SNPs and triplet repeats (10) . Numerous studies have shown relationships between CNR1 gene polymorphisms and basal metabolic index, obesity, anorexia nervosa, bulimia nervosa, irritable bowel syndrome, and various metabolic parameters (8, (17) (18) (19) (20) (21) (22) (23) . Additionally, CNR1 gene polymorphisms were also associated with disorders such as drug and alcohol abuse, schizophrenia, antipsychotic-induced weight gain in schizophrenia, Parkinson's disease, and cannabis dependence (4, 7, 8, (24) (25) (26) . Some researchers studied the relationship between CNR1 gene polymorphisms and increased body mass index and decreased adiponectin levels (9, 21, 27) . In our study, we found a statistically significant association between CNR1 gene polymorphisms and parasuicide. All the subjects with the AA genotype were in the parasuicide group.
In general, the frequency of the genotypes differs according to studies. In our study, the AG genotype was found to be lower in frequency compared to other academic works (21.7% vs 34%-46%) (9, 24, (28) (29) (30) (31) . This may be due to the different patient groups (the patient group was parasuicide in our study). To clarify the difference due to gene polymorphism in our parasuicide patients, blood EC levels and receptor sensitivities should be analyzed in further studies.
The prefrontal cortex is accepted as an essential cortical area that participates in a brain connection commonly believed to be involved in the pathophysiology of depression and suicidal behavior. Impaired decision-making likely occurs as a result of altered mood and emotion, and this might be a risk factor for suicidal behavior (5). It is suggested that the sensitization of CB1 receptors in the prefrontal cortex is a factor in the pathophysiology of suicide (10) . Impulsive behavior is one of the contributing factors for suicidal behavior; thus, another brain region that might be associated with suicidal behavior is the ventral striatum, which has been shown to mediate anhedonia and impulsive behavior (32, 33) . Consequently, these findings point out that the dysfunction of the EC system in the frontocortico-striatal circuitry possibly provokes behavioral deficits associated with suicidal behavior (33) . Alterations in the levels of ECs and in the density and coupling efficacy of CB1 receptors have been reported in the dorsolateral prefrontal cortex of both depressed and alcoholic suicide victims compared to controls (5, 16, 34, 35) .
Suicide alone is a hard field to study, as anxiety, depression, and suicide share common etiological, genetic, and neurobiological risk factors. Additional factors (e.g., impulsivity, aggression, seasons, sex, and cultural norms) also have significant contributions. Although anxiety has the highest prevalence in the population, depression is the most common psychiatric disorder that is associated with completed suicides (36) . In our study, patients who were diagnosed with depression had a higher frequency of the AA homozygous mutant genotype, but the group was not large enough to be significant. Screening for CNR1 polymorphisms in depressive patients may help determine which patients are at risk for suicide attempts. However, our knowledge about the role of the EC system in parasuicide patients is still not sufficient due to a dearth of research (5) . A suicide-related phenotype (e.g., depression, anxiety, or suicidal behavior) is a multifactorial, polygenic condition, so several genes and different polymorphisms play roles. An association between suicide and the serotonin transporter (SLC6A4), catechol-Omethyltransferase (COMT), and tryptophan hydroxylase (TPH) genes has been reported (2) . Detailed studies about SLC6A4 have showed that it was not only associated with suicidal behavior, but also with suicide-related endorphin types and traits, such as impulsive, aggressive, angerrelated, neurotic, and anxiety-related traits (37) . Lazary et al. demonstrated the interaction between CNR1 promoter variants and the functional polymorphism of the serotonin transporter gene 5-HTTLPR on trait anxiety and temperament measures in a sample of the general population. The probability of scoring higher on the anxiety scale (Brief Symptoms Inventory) was 4.6-fold greater in persons who were homozygous GG of the rs2180619 promoter polymorphism in CNR1 and also homozygous SS of 5-HTTLPR (38) . Our results offer that variants of the CB1 receptor gene (CNR1) alone may suggest that high-risk individuals for suicide attempts might be identified through genetic testing.
There were some limitations of our study. First, the risk population could have been characterized more precisely by including the previous risk phenotype (e.g., family and individual history of depression or anxiety disorder, neuroticism, or rumination) and risk environmental factors (e.g., childhood abuse or recent life stressors) in addition to genetic tests. Second, cannabis dependence has been found to be associated with increased rates of psychotic and depressive symptoms and suicide attempts. In addition, associations among alcohol addiction, depression, and suicidality have been suggested. We did not study whether these dependencies occurred in our patient group. Lastly, this study possessed only a modest sample size, hence the results could not be generalized to general population. Future studies with larger samples are needed to confirm these observations. In conclusion, our findings include:1) the frequency of the AG genotype was significantly lower in parasuicide patients than it was in normal controls. Having the AG phenotype lowered the admission rate to the ED due to parasuicide by 3.3 times (95% CI: 1.6-6.8); 2) the frequency of the AG genotype was significantly lower in parasuicide patients with a previous psychiatric diagnosis compared to suicide attempts without a previous diagnosis; and 3) AA polymorphism was relatively rare and may be associated with parasuicide as there were no control subjects with this polymorphism, but larger studies are needed to prove this. As far as we know, this study is the first in the literature showing a preventive association between CNR1 rs1049353 (1359 G/A) gene polymorphism and parasuicide patients. CNR1 receptor polymorphisms might be used as a biological test to help clinicians in predicting and preventing suicidality risk,if the relationship can be confirmed with further studies. Preventive strategies would be improved by increasing knowledge of the pathophysiological disturbances that underlie suicide attempts.
